Feldt-Rasmussen B F, Borch-Johnsen K, Deckert T, Jensen G, Jensen J S
Endokrinologisk afdeling P, Rigshospitalet, København.
Ugeskr Laeger. 1993 Dec 20;155(51):4149-54.
The concept of microalbuminuria is reviewed. Measuring the urinary albumin excretion rate and testing for microalbuminuria is well established in the control and treatment of patients with insulin-dependent diabetes mellitus. Microalbuminuria predicts nephropathy and early cardiovascular death. In the presence of microalbuminuria, frequent examinations are warranted for early detection of retinopathy, hypertension and for optimizing the glycaemic control. In patients with non-insulin dependent diabetes, the independent value of microalbuminuria as a cardiovascular risk factor is not yet clarified. The urinary albumin excretion rate should be measured at diagnosis, because the indications are that presence of microalbuminuria reinforces the urge to intervene against other well-documented cardiovascular risk-factors (hypertension, dyslipidemia, tobacco and obesity). In the non-diabetic population there is accumulating evidence that an elevated urinary albumin excretion rate is associated with early cardiovascular morbidity and mortality. Large scale cross-sectional and prospective studies are needed in order to further clarify the role of microalbuminuria as an independent risk factor in the background population.
本文对微量白蛋白尿的概念进行了综述。在胰岛素依赖型糖尿病患者的控制和治疗中,测量尿白蛋白排泄率及检测微量白蛋白尿已得到广泛应用。微量白蛋白尿可预测肾病和早期心血管死亡。出现微量白蛋白尿时,有必要频繁检查以早期发现视网膜病变、高血压并优化血糖控制。在非胰岛素依赖型糖尿病患者中,微量白蛋白尿作为心血管危险因素的独立价值尚未明确。诊断时应测量尿白蛋白排泄率,因为有迹象表明微量白蛋白尿的存在会增强针对其他已充分证实的心血管危险因素(高血压、血脂异常、吸烟和肥胖)进行干预的紧迫性。在非糖尿病人群中,越来越多的证据表明尿白蛋白排泄率升高与早期心血管疾病的发病率和死亡率相关。需要进行大规模的横断面研究和前瞻性研究,以进一步阐明微量白蛋白尿作为背景人群中独立危险因素的作用。